Practical considerations of new drugs: new choices for old problems.

Author(s): Frank T

Affiliation(s): Area Health Education Center--Northeast, University of Arkansas for Medical Sciences, Jonesboro, USA. tfrank@ahecne.uams.edu

Publication date & source: 2006-04, Consult Pharm., 21(4):276-8, 281-83.

Publication type:

As drug therapy experts, pharmacists are often called upon for facts and opinions about recently introduced drugs. New drugs are introduced at a rate that exceeds the reading time of many busy practitioners. This article is intended to provide an objective information and broad-based discussion about new drug options that have particular relevance for the elderly. Drugs that will be reviewed include: acamprosate, darifenacin, eszopiclone, exenatide, ibandronate, nitazoxanide, pramlintide, pregabalin, ramelteon, tigecycline, tinidazole, trospium, and solifenacin.